The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic
heterogeneity. Several risk factors including advanced age, previous illnesses, and a …

The severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV-2) poses a
threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID …

Patients diagnosed with B-cell non-Hodgkin lymphoma (B-NHL), particularly if recently
treated with anti-CD20 antibodies, are at risk of severe COVID-19 disease. Because studies …

Background: Cancer patients show increased morbidity with COVID-19 and need effective
immunization strategies. Many healthcare regulatory agencies recommend administering …

Background: Since the beginning of the SARS-CoV-2 pandemic, cancer patients affected by
COVID-19 have been reported to experience poor prognosis; however, a detailed …

Simple Summary Patients with active malignancies have an increased risk for severe SARS-
CoV-2 infection and high mortality from COVID-19. Additionally, due to the underlying …

COVID-19 has been responsible for widespread morbidity and mortality worldwide. Invasive
mucormycosis has death rates scaling 80%. India, one of the countries hit worst by the …

Background/Aim: This study aimed to assess the impact of the ongoing COVID-19 pandemic
on cancer patients, known to be immune-compromised due to the disease itself, oncological …

Background Prior studies, generally conducted at single centers with small sample sizes,
found that individuals with cancer experience more severe outcomes due to COVID-19 …

The spread of coronavirus disease 2019 (COVID-19), with the two peaks of infection
documented worldwide (February 2020-June 2020 and September 2020-April 2021) …